Table 2 Maternal and neonatal/perinatal outcomes in women with gestational diabetes mellitus (GDM) treated vs. not treated with myoinositol
Patients treated with myoinositol (n= 150) | Patients not treated with myoinositol (n= 180) | P | |
|---|---|---|---|
Subjects (%) | Subjects (%) | ||
Obstetrical outcomes | |||
Gestational hypertension | 9 (6%) | 7 (3.8%) | 0.150 |
Preeclampsia | 9 (6%) | 5 (2.7%) | 0.137 |
Preterm delivery | 8 (5.3%) | 16 (8.8%) | 0.055 |
Caesarean rate | 40 (26.6%) | 36 (20%) | 0.156 |
Recurrent glycosuria | 13 (8.6%) | 16 (8.8%) | 0.948 |
Recurrent ketonuria | 35 (23.3%) | 33 (18.3%) | 0.263 |
Mean ± SD | Mean ± SD | ||
Neonatal and perinatal outcomes | |||
Birth weight (g) | 3241 ± 443 | 3361 ± 406 | 0.043 |
Birth weight percentiles | 72.6 ± 12.6 | 75.4 ± 13.7 | 0.056 |
Birth length (cm) | 49.6 ± 1.83 | 49.3 ± 1.87 | 0.426 |
Birth length percentiles | 60 ± 16.6 | 59.2 ± 18.6 | 0.703 |
APGAR score | 8.89 ± 0.91 | 9.13 ± 0.77 | 0.070 |
Subjects (%) | Subjects (%) | ||
Large for gestational age (LGA) | 13 (8.8%) | 13 (7.2%) | 0.592 |
Small for gestational age (SGA) | 12 (8%) | 25 (13.8%) | 0.096 |
Hypoglycaemia | 11 (7.3%) | 36 (20%) | 0.001 |
NICU stay | 8 (5.3%) | 5 (2.7%) | 0.224 |
Hyperbilirubinemia | 18 (12%) | 12 (6.6%) | 0.089 |
Respiratory distress syndrome | 4 (2.6%) | 3 (1.6%) | 0.524 |